Edward D. Pergament
Kaplan Gilman Pergament LLPGeneral
Experience14 yrs
Elite Ratings
--
Practice Areas
Biotech (29 cases)
Reexam/Aband. (4 cases)
Mech Eng, Manuf (3 cases)
Ratings
Experience
Grade
Trend
DCT
L1
E
PTAB
L1
D
CAFC
--
--
--
Cases
Case # | Court | Caption | Filed | Represent |
|---|---|---|---|---|
| 1:23-CV-00923 | Pfizer Inc v. Aurobindo Pharma Ltd | 08/23/23 | Challenger | |
| 1:23-CV-00924 | Pfizer Inc v. Zenara Pharma Pvt Ltd | 08/23/23 | Challenger | |
| 1:23-CV-00714 | Intercept Pharmaceuticals, Inc. v. Zenara Pharma Private Limited | 06/30/23 | Challenger | |
| 1:23-CV-00039 | Merck KGaA v. Aurobindo Pharma USA Inc | 01/13/23 | Challenger | |
| 1:22-CV-01423 | AbbVie Inc v. Alkem Laboratories Ltd | 10/27/22 | ||
| 1:22-CV-01365 | Merck KGaA v. Hopewell Pharma Ventures Inc | 10/17/22 | Challenger | |
| 1:22-CV-01215 | Intercept Pharmaceuticals, Inc. v. Zenara Pharma Private Limited | 09/16/22 | Challenger | |
| 1:22-CV-00377 | Merck Sharp & Dohme Corp v. Aurobindo Pharma Ltd | 03/23/22 | ||
| 1:22-CV-00378 | PF Prism Imb BV v. Hetero USA Inc | 03/23/22 | Challenger | |
| 1:22-CV-00379 | Merck Sharp & Dohme Corp v. Zenara Pharma Pvt Ltd | 03/23/22 | Challenger |